Clinical and laboratory predictors of clomiphene response**Supported in part by Grant HD 05932 from the National Institutes of Health, United States Public Health Service, Bethesda, Maryland, and by a grant from the Ford Foundation.-Reference-Cited by-同舟云学术

Clinical and laboratory predictors of clomiphene response**Supported in part by Grant HD 05932 from the National Institutes of Health, United States Public Health Service, Bethesda, Maryland, and by a grant from the Ford Foundation.

Published:1982-02 Issue:2 Volume:37 Page:168-174
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Lobo Rogerio A.,Gysler Mathias,March Charles M.,Goebelsmann Uwe,Mishell Daniel R.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference25 articles.

1. An individualized graduated therapeutic regimen for clomiphene citrate;Rust;Am J Obstet Gynecol,1972

2. Extended experience with an individualized clomiphene treatment regimen;Gysler;Fertil Steril,1980

3. Relationship of weight to successful induction of ovulation with clomiphene citrate;Shepard;Fertil Steril,1979

4. Reduced sex hormone binding globulin (SHBG) and increased free estradiol in obese women (Abstr 567);Hammond,1979

5. Obesity and oligomenorrhea associated with hyperandrogenism independent of hirsutism;Hosseinian;J Clin Endocrinol Metab,1976

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of Newly Devised Clomiphene Citrate Administration Method Compared with the Conventional Method in Ovulation and Pregnancy;Open Journal of Obstetrics and Gynecology;2024

2. Ovulation induction techniques in women with polycystic ovary syndrome;Frontiers in Medicine;2022-08-12

3. Polycystic Ovary Syndrome: Ovulation Induction Strategies;Ovarian Stimulation;2022-04-30

4. Ovarian response to follicle‐stimulating hormone in women with polycystic ovary syndrome is diminished compared to ovulatory controls;Clinical Endocrinology;2022-03-14

5. Could Cytochrome P450 2D6, 3A4 and 3A5 Polymorphisms Explain the Variability in Clinical Response to Clomiphene Citrate of Anovulatory PCOS Women?;Frontiers in Endocrinology;2021-10-08